Esther W. Chan
Impact in
- Gastroenterology top 2%
- Gastroesophageal reflux and treatments
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 37
- COVID-19 Clinical Research Studies 14
-
- Atrial Fibrillation Management and Outcomes 26
- Co-authors
- Ian Chi Kei Wong (232 shared papers)Celine Sze Ling Chui (101 shared papers)Wai K. Leung (32 shared papers)Kenneth K. C. Man (45 shared papers)Wallis C. Y. Lau (37 shared papers)Ka Shing Cheung (23 shared papers)Angel Wong (18 shared papers)Lijia Chen (14 shared papers)
- Journals
- Drug Safety (10 papers)The Lancet Regional Health - Western Pacific (8 papers)PLoS ONE (7 papers)Pharmacoepidemiology and Drug Safety (7 papers)CNS Drugs (6 papers)
- Partner nations
- Hong KongUnited KingdomChina
In The Last Decade
Esther W. Chan
279 papers receiving 5.8k citations
Esther W. Chan's Hit Papers
Peers
Comparison fields: 5 of 165
- Gastroenterology 205
- Infectious Diseases 715
- Internal Medicine 126
- Cardiology and Cardiovascular Medicine 801
- Psychiatry and Mental health 500
Countries citing papers authored by Esther W. Chan
This map shows the geographic impact of Esther W. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther W. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther W. Chan more than expected).
Fields of papers citing papers by Esther W. Chan
This network shows the impact of papers produced by Esther W. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther W. Chan. The network helps show where Esther W. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Esther W. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 300 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori : a population-based study Hit paper breakdown → | 2017 | 317 |
| 2 | 2016 | 180 | |
| 3 | 2015 | 177 | |
| 4 | 2017 | 151 | |
| 5 | 2018 | 126 | |
| 6 | 2016 | 118 | |
| 7 | 2021 | 103 | |
| 8 | 2017 | 95 | |
| 9 | 2014 | 90 | |
| 10 | 2012 | 89 | |
| 11 | Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank Hit paper breakdown → | 2023 | 83 |
| 12 | 2021 | 81 | |
| 13 | 2014 | 77 | |
| 14 | 2021 | 75 | |
| 15 | Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study | 2022 | 71 |
| 16 | 2023 | 70 | |
| 17 | 2018 | 68 | |
| 18 | 2013 | 68 | |
| 19 | 2016 | 63 | |
| 20 | 2021 | 62 |
About Esther W. Chan
Esther W. Chan is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Psychiatry and Mental health, Surgery and Clinical Psychology, having authored 300 papers that have together received 5.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (37 papers), Atrial Fibrillation Management and Outcomes (26 papers), COVID-19 Clinical Research Studies (14 papers), Attention Deficit Hyperactivity Disorder (12 papers), Healthcare Decision-Making and Restraints (12 papers), Schizophrenia research and treatment (10 papers), Lipoproteins and Cardiovascular Health (8 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). The work is most often cited by research in Gastroenterology (205 citations), Infectious Diseases (715 citations), Internal Medicine (126 citations), Cardiology and Cardiovascular Medicine (801 citations) and Psychiatry and Mental health (500 citations). Esther W. Chan has collaborated with scholars based in Hong Kong, United Kingdom and China. Frequent co-authors include Ian Chi Kei Wong, Celine Sze Ling Chui, Wai K. Leung, Kenneth K. C. Man, Wallis C. Y. Lau, Ka Shing Cheung, Angel Wong, Lijia Chen, Xue Li and Eric Yuk Fai Wan. Their work appears in journals such as Drug Safety, The Lancet Regional Health - Western Pacific, PLoS ONE, Pharmacoepidemiology and Drug Safety and CNS Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.